![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan
The mutation in the
1A subunit gene of the P/Q-type (Cav2.1) Ca2+ channel present in tottering (tg) mice causes ataxia and motor seizures that resemble absence epilepsy in humans. P/Q-type Ca2+channels are primarily involved in acetylcholine (ACh) release at mammalian neuromuscular junctions. Unmasking of L-type (Cav1.11.2) Ca2+ channels occurs in cerebellar Purkinje cells of tg mice. However, whether L-type Ca2+ channels are also up-regulated at neuromuscular junctions of tg mice is unknown. We characterized thoroughly the pharmacological sensitivity of the Ca2+ channels, which control ACh release at adult tg neuromuscular junctions. Block of N- and R-type (Cav2.22.3), but not L-type Ca2+ channels, significantly reduced quantal content of end-plate potentials in tg preparations. Neither resting nor KCl-evoked miniature end-plate potential frequency differed significantly between tg and wild type (WT). Immunolabeling of Ca2+ channel subunits
1A,
1B,
1C, and
1E revealed an apparent increase of
1B, and
1E staining, at tg but not WT neuromuscular junctions. This presumably compensates for the deficit of P/Q-type Ca2+channels, which localized presynaptically at WT neuromuscular junctions. No
1C subunits juxtaposed with pre- or postsynaptic markers at either WT or tg neuromuscular junctions. Thus, in adult tg mice, immunocytochemical and electrophysiological data indicate that N- and R-type channels both assume control of ACh release at motor nerve terminals. Recruitment of alternate subtypes of Ca2+ channels to control transmitter release seems to represent a commonly occurring method of neuronal plasticity. However, it is unclear which conditions underlie recruitment of Cav2 as opposed to Cav1-type Ca2+ channels.
Address correspondence to: Dr. William D. Atchison, Department of Pharmacology and Toxicology, Michigan State University, B-331 Life Sciences Bldg., East Lansing, MI 48824-1317. E-mail: atchiso1{at}msu.edu